Summary: The Food and Drug Administration (FDA) is still facing internal issues, yet investors on Wall surface Road appear to be paying it no mind, according to current monitorings.
Bottom line
- The Food and Drug Administration (FDA) continues to experience internal turmoil.
- Wall surface Road is evidently unconcerned about the FDA’s ongoing challenges.
What This Suggests
For the Indian market, this suggests that investment choices related to pharmaceutical or food companies influenced by FDA laws might not be dramatically affected by the FDA’s internal issues. Indian business wanting to export to the United States will still require to abide by FDA requirements, irrespective of these interior problems.
Source: www.wsj.com